Excellent visual outcomes in cataract surgery

Article

Cataract surgery produces excellent visual outcomes, with 61.3% of patients achieving a corrected distance visual acuity of 20/20 or better, according to a database study in the Journal of Cataract and Refractive Surgery.

Cataract surgery produces excellent visual outcomes, with 61.3% of patients achieving a corrected distance visual acuity of 20/20 or better, according to a database study in the Journal of Cataract and Refractive Surgery.

Dr Mats Lundström and his team, Department Ophthalmology, Faculty of Medicine, Lund University, Lund, Sweden, included data on 368,256 cataract extractions from 15 cataract surgery clinics in Europe. The data consisted of individual anonymous data on preoperative, intraoperative and postoperative measurements.

The best visual outcome was seen in age groups 40 to 74 years and men presented a higher percentage of excellent vision. Corrected distance visual acuity (CDVA) of 20/40 or better was achieved in 94.3% and 20/20 or better was obtained in 61.3% of patients.

Overall, the factors that greatly affected visual outcomes were ocular comorbidity and postoperative complications. Also, surgical complications and ocular changes that needed complex surgery also negatively affected outcomes.

The abstract can be viewed here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.